Compositions for use in identification of bacteria

Details for Australian Patent Application No. 2005322640 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Ecker, David J.; Hall, Thomas A.; Massire, Christian; Sampath, Rangarajan; Eshoo, Mark W.

Agent Spruson & Ferguson

Pub. Number AU-B-2005322640

PCT Pub. Number WO2006/071241

Priority 60/545,425 18.02.04 US; 60/559,754 05.04.04 US; 60/632,862 03.12.04 US; 60/639,068 22.12.04 US; 60/648,188 28.01.05 US

Filing date 18 February 2005

Wipo publication date 6 July 2006

Acceptance publication date 18 September 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2006/071241 Priority application(s): WO2006/071241

18 September 2008 Application Accepted

  Published as AU-B-2005322640

25 September 2008 Assignment before Grant

  Isis Pharmaceuticals, Inc. The application has been assigned to Ibis Biosciences, Inc. 2006

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322648-High discharge capacity lithium battery

2005322637-Small form factor optical connector with thermoplastic adhesive